Annual SG&A
$488.43M$81.87M+20.14%
Summary
- Current Value
- As of today, ACAD annual SG&A is $488.43M, up +20.14% on
- Historical Performance
- ACAD annual SG&A is up +23.33% over the past 3 years, and up +49.99% over the past 5 years
- All-Time High Comparison
- ACAD annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- ACAD annual SG&A is +32.33% above its 3-year low of $369.09M reached on an earlier date
- Sector Comparison
- ACAD annual SG&A is higher than 94.42% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $488.43M | +20.1% | +23.3% | +50.0% | +4650.3% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$8.64B | -1938.1% | -2431.0% | -2450.9% | -10000.0% | |
| Price | $27.42 | +57.7% | +58.5% | -50.1% | +2284.3% | |
| Annual Operating Expenses | $791.68M | +4.4% | +24.6% | +39.9% | +1426.4% | |
| Annual Operating Profit | $84.28M | +214.8% | +149.4% | +134.2% | +285.4% | |
| Annual D&A | $15.88M | +186.1% | +375.0% | +474.2% | +1329.6% | |
| Annual Revenue | $957.80M | +31.9% | +97.8% | +182.5% | +10000.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $488.43M | at high | |
| 5Y | $488.43M | at high | |
| All | $488.43M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $369.09M | N/A | +32.3% |
| 5Y | $369.09M | +32.3% | |
| All | $3.00M | >+9999.0% |
SG&A History
FAQ
What is the current annual SG&A of ACAD?
As of today, ACAD annual SG&A is $488.43M
What is 1-year change in ACAD annual SG&A?
ACAD annual SG&A is up +20.14% year-over-year
What is 3-year change in ACAD annual SG&A?
ACAD annual SG&A is up +23.33% over the past 3 years
How far is ACAD annual SG&A from its all-time high?
ACAD annual SG&A is currently at its all-time high
How does ACAD annual SG&A rank versus sector peers?
ACAD annual SG&A is higher than 94.42% of companies in Healthcare sector
When is ACAD next annual earnings release?
The next annual earnings release for ACAD is on
Quarterly SG&A
$0.00$133.51M-100.00%
Summary
- Current Value
- As of today, ACAD quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- ACAD quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- ACAD quarterly SG&A is currently -100.00% below its historical high of $133.51M set on
- 3-Year Low Comparison
- ACAD quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- ACAD quarterly SG&A is higher than 45.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $488.43M | – | +20.1% | +23.3% | +50.0% | |
| TTM SG&A | -$8.64B | -1750.3% | -1938.1% | -2431.0% | -2450.9% | |
| Price | $27.42 | +27.3% | +57.7% | +58.5% | -50.1% | |
| Quarterly Operating Expenses | $221.23M | +4.6% | +10.7% | +38.8% | +46.3% | |
| Quarterly Operating Profit | $35.76M | +10.4% | +13.0% | +215.8% | +208.0% | |
| Quarterly D&A | $2.95M | +0.5% | +14.8% | +483.0% | +317.3% | |
| Quarterly Revenue | $278.63M | +5.3% | +11.3% | +113.2% | +131.1% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $133.51M | -100.0% | |
| 3Y | $133.51M | -100.0% | |
| 5Y | $133.51M | -100.0% | |
| All | $133.51M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of ACAD?
As of today, ACAD quarterly SG&A is $0.00
What is ACAD quarterly SG&A most recent change?
ACAD quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in ACAD quarterly SG&A?
ACAD quarterly SG&A is down -100.00% year-over-year
How far is ACAD quarterly SG&A from its all-time high?
ACAD quarterly SG&A is currently -100.00% below its historical high of $133.51M set on June 30, 2025
How does ACAD quarterly SG&A rank versus sector peers?
ACAD quarterly SG&A is higher than 45.54% of companies in Healthcare sector
When is ACAD next earnings release?
The next earnings release for ACAD is on
TTM SG&A
-$8.64B$261.17M+2.94%
Summary
- Current Value
- As of today, ACAD TTM SG&A is -$8.64B, up +2.94% on
- Historical Performance
- ACAD TTM SG&A is down -1938.07% year-over-year, and down -2431.03% over the past 3 years
- All-Time High Comparison
- ACAD TTM SG&A is currently -12531.26% below its historical high of -$68.37M set on an earlier date
- 3-Year Low Comparison
- ACAD TTM SG&A is +11.28% above its 3-year low of -$9.73B reached on an earlier date
- Sector Comparison
- ACAD TTM SG&A is higher than 4.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$8.64B | -1750.3% | -1938.1% | -2431.0% | -2450.9% | |
| Annual SG&A | $488.43M | – | +20.1% | +23.3% | +50.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $27.42 | +27.3% | +57.7% | +58.5% | -50.1% | |
| TTM Operating Profit | $94.41M | +4.5% | -15.9% | +142.5% | +142.3% | |
| TTM D&A | $14.05M | +2.8% | +14.2% | +578.1% | +414.8% | |
| TTM Revenue | $1.05B | +2.8% | +12.7% | +104.7% | +149.9% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$8.64B | N/A | at high |
| 3Y | -$8.64B | N/A | at high |
| 5Y | -$7.53B | N/A | -14.7% |
| All | -$68.37M | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$9.35B | N/A | +7.6% |
| 3Y | -$9.73B | N/A | +11.3% |
| 5Y | -$9.73B | N/A | +11.3% |
| All | -$9.73B | N/A | +11.3% |
TTM SG&A History
FAQ
What is the current TTM SG&A of ACAD?
As of today, ACAD TTM SG&A is -$8.64B
What is ACAD TTM SG&A most recent change?
ACAD TTM SG&A was up +2.94% on September 30, 2025
What is 1-year change in ACAD TTM SG&A?
ACAD TTM SG&A is down -1938.07% year-over-year
How does ACAD TTM SG&A rank versus sector peers?
ACAD TTM SG&A is higher than 4.09% of companies in Healthcare sector
When is ACAD next earnings release?
The next earnings release for ACAD is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- ACAD Official Website www.acadia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1070494/000119312525267453/0001193125-25-267453-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1070494/000095017025029253/0000950170-25-029253-index.htm
- ACAD Profile on Yahoo Finance finance.yahoo.com/quote/ACAD
- ACAD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acad